Brain bleed drug trial halted early – what we know
NCT ID NCT05953103
First seen Apr 11, 2026 · Last updated Apr 28, 2026 · Updated 1 time
Summary
This study tested a drug called edaravone dexborneol in people who had a brain bleed (cerebral hemorrhage). The goal was to see if different doses were safe and helped recovery when added to standard care. The trial was stopped early, and it involved 80 adults with small to medium bleeds in a specific brain area.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBJECTS WITH CEREBRAL HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.